Abbott Laboratories (ABT) Social Stream
ABBOTT LABORATORIES (ABT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 15 | $146 | $125 | $136.846 | $104.84 | 30.53% |
| 2021-12-10 | 15 | $146 | $125 | $137.846 | $104.84 | 31.48% |
| 2021-12-22 | 14 | $150 | $125 | $138.583 | $104.84 | 32.19% |
| 2022-01-24 | 14 | $157 | $125 | $140.333 | $104.84 | 33.85% |
| 2022-01-27 | 14 | $151 | $125 | $139.25 | $104.84 | 32.82% |
| 2022-04-11 | 14 | $151 | $125 | $139.307 | $104.84 | 32.88% |
| 2022-04-14 | 14 | $151 | $125 | $140.461 | $104.84 | 33.98% |
| 2022-05-18 | 14 | $151 | $125 | $139.846 | $104.84 | 33.39% |
| 2022-06-07 | 10 | $150 | $125 | $140.636 | $104.84 | 34.14% |
| 2022-06-13 | 10 | $150 | $125 | $139.727 | $104.84 | 33.28% |
| 2022-07-22 | 12 | $150 | $95 | $127.083 | $104.84 | 21.22% |
| 2022-08-24 | 13 | $150 | $95 | $127.153 | $104.84 | 21.28% |
The Trend in the Analyst Price Target
Over the past 32 weeks, ABT's average price target has gone down $13.18.
Over the past 51 weeks, ABT's average upside potential has been 14.34%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-11 | 26 | 158 | 109 | 132.050 | 128.80 | 2.52% |
| 2021-12-10 | 15 | 146 | 125 | 137.846 | 134.37 | 2.59% |
| 2022-01-27 | 14 | 151 | 125 | 139.250 | 120.44 | 15.62% |
| 2022-04-11 | 14 | 151 | 125 | 139.307 | 120.04 | 16.05% |
| 2022-05-18 | 10 | 151 | 125 | 141.083 | 112.74 | 25.14% |
ABT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.15 | 11 | 2 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 52 weeks, ABT's average broker recommendation rating improved by 0.65.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABT as an investment opportunity.
- ABT has a higher average analyst price target than 1715.61% of Pharmaceutical Products stocks.
- In the context of stocks in the mega market cap category, ABBOTT LABORATORIES's variance in analysts' estimates is lower than -124.28% of them.
- ABBOTT LABORATORIES's number of analysts covering the stock is higher than 1680.49% of Pharmaceutical Products stocks.
- ABT has a greater upside potential (average analyst target price relative to current price) than 335.14% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABBOTT LABORATORIES are ABBV, TECH, and SGEN.
View All Top Stocks by Price Target
Is ABT a Buy, Hold or Sell? See the POWR Ratings now!